1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Antisense Oligonucleotides Revenue 1.4 Market Analysis by Type 1.4.1 Global Antisense Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 RNA Antisense Oligonucleotides 1.4.3 DNA Antisense Oligonucleotides 1.5 Market by Application 1.5.1 Global Antisense Oligonucleotides Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinic 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Antisense Oligonucleotides Industry Impact 1.6.1 How the Covid-19 is Affecting the Antisense Oligonucleotides Industry 1.6.1.1 Antisense Oligonucleotides Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Antisense Oligonucleotides Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Antisense Oligonucleotides Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Antisense Oligonucleotides Market Perspective (2015-2026) 2.2 Antisense Oligonucleotides Growth Trends by Regions 2.2.1 Antisense Oligonucleotides Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Antisense Oligonucleotides Historic Market Share by Regions (2015-2020) 2.2.3 Antisense Oligonucleotides Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Antisense Oligonucleotides Market Growth Strategy 2.3.6 Primary Interviews with Key Antisense Oligonucleotides Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Antisense Oligonucleotides Players by Market Size 3.1.1 Global Top Antisense Oligonucleotides Players by Revenue (2015-2020) 3.1.2 Global Antisense Oligonucleotides Revenue Market Share by Players (2015-2020) 3.1.3 Global Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Antisense Oligonucleotides Market Concentration Ratio 3.2.1 Global Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides Revenue in 2019 3.3 Antisense Oligonucleotides Key Players Head office and Area Served 3.4 Key Players Antisense Oligonucleotides Product Solution and Service 3.5 Date of Enter into Antisense Oligonucleotides Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Antisense Oligonucleotides Historic Market Size by Type (2015-2020) 4.2 Global Antisense Oligonucleotides Forecasted Market Size by Type (2021-2026) 5 Antisense Oligonucleotides Breakdown Data by Application (2015-2026) 5.1 Global Antisense Oligonucleotides Market Size by Application (2015-2020) 5.2 Global Antisense Oligonucleotides Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Antisense Oligonucleotides Market Size (2015-2020) 6.2 Antisense Oligonucleotides Key Players in North America (2019-2020) 6.3 North America Antisense Oligonucleotides Market Size by Type (2015-2020) 6.4 North America Antisense Oligonucleotides Market Size by Application (2015-2020) 7 Europe 7.1 Europe Antisense Oligonucleotides Market Size (2015-2020) 7.2 Antisense Oligonucleotides Key Players in Europe (2019-2020) 7.3 Europe Antisense Oligonucleotides Market Size by Type (2015-2020) 7.4 Europe Antisense Oligonucleotides Market Size by Application (2015-2020) 8 China 8.1 China Antisense Oligonucleotides Market Size (2015-2020) 8.2 Antisense Oligonucleotides Key Players in China (2019-2020) 8.3 China Antisense Oligonucleotides Market Size by Type (2015-2020) 8.4 China Antisense Oligonucleotides Market Size by Application (2015-2020) 9 Japan 9.1 Japan Antisense Oligonucleotides Market Size (2015-2020) 9.2 Antisense Oligonucleotides Key Players in Japan (2019-2020) 9.3 Japan Antisense Oligonucleotides Market Size by Type (2015-2020) 9.4 Japan Antisense Oligonucleotides Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Antisense Oligonucleotides Market Size (2015-2020) 10.2 Antisense Oligonucleotides Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Antisense Oligonucleotides Market Size by Type (2015-2020) 10.4 Southeast Asia Antisense Oligonucleotides Market Size by Application (2015-2020) 11 India 11.1 India Antisense Oligonucleotides Market Size (2015-2020) 11.2 Antisense Oligonucleotides Key Players in India (2019-2020) 11.3 India Antisense Oligonucleotides Market Size by Type (2015-2020) 11.4 India Antisense Oligonucleotides Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Antisense Oligonucleotides Market Size (2015-2020) 12.2 Antisense Oligonucleotides Key Players in Central & South America (2019-2020) 12.3 Central & South America Antisense Oligonucleotides Market Size by Type (2015-2020) 12.4 Central & South America Antisense Oligonucleotides Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Ionis Pharmaceuticals 13.1.1 Ionis Pharmaceuticals Company Details 13.1.2 Ionis Pharmaceuticals Business Overview and Its Total Revenue 13.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Introduction 13.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)) 13.1.5 Ionis Pharmaceuticals Recent Development 13.2 Sarepta Therapeutics 13.2.1 Sarepta Therapeutics Company Details 13.2.2 Sarepta Therapeutics Business Overview and Its Total Revenue 13.2.3 Sarepta Therapeutics Antisense Oligonucleotides Introduction 13.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) 13.2.5 Sarepta Therapeutics Recent Development 13.3 Biogen 13.3.1 Biogen Company Details 13.3.2 Biogen Business Overview and Its Total Revenue 13.3.3 Biogen Antisense Oligonucleotides Introduction 13.3.4 Biogen Revenue in Antisense Oligonucleotides Business (2015-2020) 13.3.5 Biogen Recent Development 13.4 Alnylam Pharmaceuticals 13.4.1 Alnylam Pharmaceuticals Company Details 13.4.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue 13.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Introduction 13.4.4 Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) 13.4.5 Alnylam Pharmaceuticals Recent Development 13.5 Antisense Therapeutics 13.5.1 Antisense Therapeutics Company Details 13.5.2 Antisense Therapeutics Business Overview and Its Total Revenue 13.5.3 Antisense Therapeutics Antisense Oligonucleotides Introduction 13.5.4 Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) 13.5.5 Antisense Therapeutics Recent Development 13.6 Isarna Therapeutics 13.6.1 Isarna Therapeutics Company Details 13.6.2 Isarna Therapeutics Business Overview and Its Total Revenue 13.6.3 Isarna Therapeutics Antisense Oligonucleotides Introduction 13.6.4 Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) 13.6.5 Isarna Therapeutics Recent Development 13.7 Arrowhead Pharmaceuticals 13.7.1 Arrowhead Pharmaceuticals Company Details 13.7.2 Arrowhead Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Introduction 13.7.4 Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) 13.7.5 Arrowhead Pharmaceuticals Recent Development 13.8 Atlantic Pharmaceuticals 13.8.1 Atlantic Pharmaceuticals Company Details 13.8.2 Atlantic Pharmaceuticals Business Overview and Its Total Revenue 13.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Introduction 13.8.4 Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) 13.8.5 Atlantic Pharmaceuticals Recent Development 13.9 Enzon Pharmaceuticals 13.9.1 Enzon Pharmaceuticals Company Details 13.9.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Introduction 13.9.4 Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) 13.9.5 Enzon Pharmaceuticals Recent Development 13.10 Bio-Path Holdings 13.10.1 Bio-Path Holdings Company Details 13.10.2 Bio-Path Holdings Business Overview and Its Total Revenue 13.10.3 Bio-Path Holdings Antisense Oligonucleotides Introduction 13.10.4 Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2015-2020) 13.10.5 Bio-Path Holdings Recent Development 13.11 GlaxoSmithKline 10.11.1 GlaxoSmithKline Company Details 10.11.2 GlaxoSmithKline Business Overview and Its Total Revenue 10.11.3 GlaxoSmithKline Antisense Oligonucleotides Introduction 10.11.4 GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2015-2020) 10.11.5 GlaxoSmithKline Recent Development 13.12 Geron 10.12.1 Geron Company Details 10.12.2 Geron Business Overview and Its Total Revenue 10.12.3 Geron Antisense Oligonucleotides Introduction 10.12.4 Geron Revenue in Antisense Oligonucleotides Business (2015-2020) 10.12.5 Geron Recent Development 13.13 ICO Therapeutics 10.13.1 ICO Therapeutics Company Details 10.13.2 ICO Therapeutics Business Overview and Its Total Revenue 10.13.3 ICO Therapeutics Antisense Oligonucleotides Introduction 10.13.4 ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) 10.13.5 ICO Therapeutics Recent Development 13.14 Marina Biotech 10.14.1 Marina Biotech Company Details 10.14.2 Marina Biotech Business Overview and Its Total Revenue 10.14.3 Marina Biotech Antisense Oligonucleotides Introduction 10.14.4 Marina Biotech Revenue in Antisense Oligonucleotides Business (2015-2020) 10.14.5 Marina Biotech Recent Development 13.15 RXi Pharmaceuticals 10.15.1 RXi Pharmaceuticals Company Details 10.15.2 RXi Pharmaceuticals Business Overview and Its Total Revenue 10.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Introduction 10.15.4 RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) 10.15.5 RXi Pharmaceuticals Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Antisense Oligonucleotides Key Market Segments Table 2. Key Players Covered: Ranking by Antisense Oligonucleotides Revenue Table 3. Ranking of Global Top Antisense Oligonucleotides Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of RNA Antisense Oligonucleotides Table 6. Key Players of DNA Antisense Oligonucleotides Table 7. COVID-19 Impact Global Market: (Four Antisense Oligonucleotides Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Antisense Oligonucleotides Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Antisense Oligonucleotides Players to Combat Covid-19 Impact Table 12. Global Antisense Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Antisense Oligonucleotides Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Antisense Oligonucleotides Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Antisense Oligonucleotides Market Share by Regions (2015-2020) Table 16. Global Antisense Oligonucleotides Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Antisense Oligonucleotides Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Antisense Oligonucleotides Market Growth Strategy Table 22. Main Points Interviewed from Key Antisense Oligonucleotides Players Table 23. Global Antisense Oligonucleotides Revenue by Players (2015-2020) (Million US$) Table 24. Global Antisense Oligonucleotides Market Share by Players (2015-2020) Table 25. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense Oligonucleotides as of 2019) Table 26. Global Antisense Oligonucleotides by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Antisense Oligonucleotides Product Solution and Service Table 29. Date of Enter into Antisense Oligonucleotides Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 32. Global Antisense Oligonucleotides Market Size Share by Type (2015-2020) Table 33. Global Antisense Oligonucleotides Revenue Market Share by Type (2021-2026) Table 34. Global Antisense Oligonucleotides Market Size Share by Application (2015-2020) Table 35. Global Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 36. Global Antisense Oligonucleotides Market Size Share by Application (2021-2026) Table 37. North America Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 38. North America Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 39. North America Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 40. North America Antisense Oligonucleotides Market Share by Type (2015-2020) Table 41. North America Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 42. North America Antisense Oligonucleotides Market Share by Application (2015-2020) Table 43. Europe Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 45. Europe Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 46. Europe Antisense Oligonucleotides Market Share by Type (2015-2020) Table 47. Europe Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 48. Europe Antisense Oligonucleotides Market Share by Application (2015-2020) Table 49. China Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 50. China Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 51. China Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 52. China Antisense Oligonucleotides Market Share by Type (2015-2020) Table 53. China Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 54. China Antisense Oligonucleotides Market Share by Application (2015-2020) Table 55. Japan Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 57. Japan Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 58. Japan Antisense Oligonucleotides Market Share by Type (2015-2020) Table 59. Japan Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 60. Japan Antisense Oligonucleotides Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 63. Southeast Asia Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Antisense Oligonucleotides Market Share by Type (2015-2020) Table 65. Southeast Asia Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Antisense Oligonucleotides Market Share by Application (2015-2020) Table 67. India Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 68. India Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 69. India Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 70. India Antisense Oligonucleotides Market Share by Type (2015-2020) Table 71. India Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 72. India Antisense Oligonucleotides Market Share by Application (2015-2020) Table 73. Central & South America Key Players Antisense Oligonucleotides Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Antisense Oligonucleotides Market Share (2019-2020) Table 75. Central & South America Antisense Oligonucleotides Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Antisense Oligonucleotides Market Share by Type (2015-2020) Table 77. Central & South America Antisense Oligonucleotides Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Antisense Oligonucleotides Market Share by Application (2015-2020) Table 79. Ionis Pharmaceuticals Company Details Table 80. Ionis Pharmaceuticals Business Overview Table 81. Ionis Pharmaceuticals Product Table 82. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 83. Ionis Pharmaceuticals Recent Development Table 84. Sarepta Therapeutics Company Details Table 85. Sarepta Therapeutics Business Overview Table 86. Sarepta Therapeutics Product Table 87. Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 88. Sarepta Therapeutics Recent Development Table 89. Biogen Company Details Table 90. Biogen Business Overview Table 91. Biogen Product Table 92. Biogen Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 93. Biogen Recent Development Table 94. Alnylam Pharmaceuticals Company Details Table 95. Alnylam Pharmaceuticals Business Overview Table 96. Alnylam Pharmaceuticals Product Table 97. Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 98. Alnylam Pharmaceuticals Recent Development Table 99. Antisense Therapeutics Company Details Table 100. Antisense Therapeutics Business Overview Table 101. Antisense Therapeutics Product Table 102. Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 103. Antisense Therapeutics Recent Development Table 104. Isarna Therapeutics Company Details Table 105. Isarna Therapeutics Business Overview Table 106. Isarna Therapeutics Product Table 107. Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 108. Isarna Therapeutics Recent Development Table 109. Arrowhead Pharmaceuticals Company Details Table 110. Arrowhead Pharmaceuticals Business Overview Table 111. Arrowhead Pharmaceuticals Product Table 112. Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 113. Arrowhead Pharmaceuticals Recent Development Table 114. Atlantic Pharmaceuticals Business Overview Table 115. Atlantic Pharmaceuticals Product Table 116. Atlantic Pharmaceuticals Company Details Table 117. Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 118. Atlantic Pharmaceuticals Recent Development Table 119. Enzon Pharmaceuticals Company Details Table 120. Enzon Pharmaceuticals Business Overview Table 121. Enzon Pharmaceuticals Product Table 122. Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 123. Enzon Pharmaceuticals Recent Development Table 124. Bio-Path Holdings Company Details Table 125. Bio-Path Holdings Business Overview Table 126. Bio-Path Holdings Product Table 127. Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 128. Bio-Path Holdings Recent Development Table 129. GlaxoSmithKline Company Details Table 130. GlaxoSmithKline Business Overview Table 131. GlaxoSmithKline Product Table 132. GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 133. GlaxoSmithKline Recent Development Table 134. Geron Company Details Table 135. Geron Business Overview Table 136. Geron Product Table 137. Geron Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 138. Geron Recent Development Table 139. ICO Therapeutics Company Details Table 140. ICO Therapeutics Business Overview Table 141. ICO Therapeutics Product Table 142. ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 143. ICO Therapeutics Recent Development Table 144. Marina Biotech Company Details Table 145. Marina Biotech Business Overview Table 146. Marina Biotech Product Table 147. Marina Biotech Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 148. Marina Biotech Recent Development Table 149. RXi Pharmaceuticals Company Details Table 150. RXi Pharmaceuticals Business Overview Table 151. RXi Pharmaceuticals Product Table 152. RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020) (Million US$) Table 153. RXi Pharmaceuticals Recent Development Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Global Antisense Oligonucleotides Market Share by Type: 2020 VS 2026 Figure 2. RNA Antisense Oligonucleotides Features Figure 3. DNA Antisense Oligonucleotides Features Figure 4. Global Antisense Oligonucleotides Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinic Case Studies Figure 7. Others Case Studies Figure 8. Antisense Oligonucleotides Report Years Considered Figure 9. Global Antisense Oligonucleotides Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Antisense Oligonucleotides Market Share by Regions: 2020 VS 2026 Figure 11. Global Antisense Oligonucleotides Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Antisense Oligonucleotides Market Share by Players in 2019 Figure 14. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense Oligonucleotides as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides Revenue in 2019 Figure 16. North America Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Antisense Oligonucleotides Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 25. Sarepta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 27. Biogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Biogen Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 29. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 31. Antisense Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Antisense Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 33. Isarna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Isarna Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 35. Arrowhead Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Arrowhead Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 37. Atlantic Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Atlantic Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 39. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Enzon Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 41. Bio-Path Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Bio-Path Holdings Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 43. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. GlaxoSmithKline Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 45. Geron Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Geron Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 47. ICO Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. ICO Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 49. Marina Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Marina Biotech Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 51. RXi Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. RXi Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2015-2020) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Ionis Pharmaceuticals Sarepta Therapeutics Biogen Alnylam Pharmaceuticals Antisense Therapeutics Isarna Therapeutics Arrowhead Pharmaceuticals Atlantic Pharmaceuticals Enzon Pharmaceuticals Bio-Path Holdings GlaxoSmithKline Geron ICO Therapeutics Marina Biotech RXi Pharmaceuticals